Crinetics Pharmaceuticals, Inc.
CRNX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$130,091 | -$115,637 | -$96,774 | -$80,595 |
| Dep. & Amort. | $1,012 | $959 | $925 | $788 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $20,478 | $18,845 |
| Change in WC | -$1,495 | $6,602 | -$9,537 | -$308 |
| Other Non-Cash | $19,856 | $22,225 | -$3,544 | -$3,404 |
| Operating Cash Flow | -$110,718 | -$85,851 | -$88,452 | -$64,674 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$863 | -$3,202 | -$1,239 | -$1,029 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$216,700 | -$182,877 | -$391,204 | -$725,028 |
| Inv. Sales/Matur. | $382,372 | $224,032 | $306,482 | $183,969 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $164,809 | $37,953 | -$85,961 | -$542,088 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $3,084 | $7,055 | $4,437 | $544,499 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $9,539 |
| Financing Cash Flow | $3,084 | $7,055 | $4,437 | $554,038 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $57,175 | -$40,843 | -$169,976 | -$52,724 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $54,226 | $95,069 | $265,045 | $318,569 |
| End Cash | $111,401 | $54,226 | $95,069 | $265,845 |
| Free Cash Flow | -$111,581 | -$89,053 | -$89,691 | -$65,703 |